Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA7 | P43166 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | APLNR | P35414 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL241533 | 0.84 | DGAT1 (0.46) | DGAT1CYP2D6CA2CA12CA14 | |
| Methyl Alcohol SCHEMBL27995686 | 0.81 | DGAT1 (0.44) | DGAT1CYP2D6CA2CA12CA14 | |
| SCHEMBL9464796 | 0.81 | CA14 (0.38) | DGAT1CYP2D6CA2CA12CA14 | |
| SCHEMBL19216586 | 0.81 | DGAT1 (0.37) | DGAT1CYP2D6CA2CA12CA14 | |
| SCHEMBL12203255 | 0.79 | DGAT1 (0.35) | DGAT1CYP2D6CA2CA12CA14 | |
| SCHEMBL18787715 | 0.79 | DGAT1 (0.40) | DGAT1CYP2D6CA2CA12CA14 | |
| SCHEMBL204758 | 0.79 | GAA (0.50) | DGAT1CA2CA12CA14KMT2A | |
| SCHEMBL28316203 | 0.79 | DGAT1 (0.42) | DGAT1CYP2D6CA2CA12CA14 | |
| SCHEMBL2648388 | 0.79 | DGAT1 (0.42) | DGAT1CYP2D6CA2CA12CA14 | |
| SCHEMBL19862462 | 0.78 | STING1 (0.37) | DGAT1CYP2D6CA2CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115461147-A | Curing catalyst and resin composition | 广荣化学株式会社 | 2022-12-09 | — | — | CN | claimed |
| JP-2763676-B2 | — | — | 1998-06-11 | — | — | JP | claimed |
| EP-0376859-B1 | METHOD FOR FUNCTIONALIZATION OF NUCLEOPHILES | EASTMAN KODAK COMPANY (US) | 1993-03-31 | — | — | EP | claimed |
| EP-0448602-A1 | METHOD FOR FUNCTIONALIZATION OF NUCLEOPHILES | EASTMAN KODAK COMPANY (US) | 1991-10-02 | — | — | EP | claimed |
| US-5051529-A | Transesterification, amidation and acetoacetylation of amines, alcohols, mercaptans and polymers | EASTMAN KODAK COMPANY (US) | 1991-09-24 | — | — | US | claimed |
| EP-0376859-A1 | Method for functionalization of nucleophiles | EASTMAN KODAK COMPANY (US) | 1990-07-04 | — | — | EP | claimed |
| WO-1990006911-A1 | METHOD FOR FUNCTIONALIZATION OF NUCLEOPHILES | EASTMAN KODAK COMPANY (US) | 1990-06-28 | — | — | WO | claimed |
| WO-2025049419-A1 | PYRAZOLYL COMPOUNDS AS EMOPAMIL BINDING PROTEIN INHIBITORS | GENZYME CORPORATION (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20240150345-A1 | GCN2 MODULATING COMPOUNDS AND USES THEREOF | PHARMARON UK LTD. (GB) | 2024-05-09 | — | — | US | disclosed |
| CN-115461147-A | Curing catalyst and resin composition | 广荣化学株式会社 | 2022-12-09 | — | — | CN | disclosed |
| WO-2022159745-A1 | GCN2 MODULATING COMPOUNDS AND USES THEREOF | HIBERCELL, INC. (US) | 2022-07-28 | — | — | WO | disclosed |
| EP-2857427-B1 | CATALYST COMPOSITION FOR POLYURETHANE RESIN PRODUCTION AND METHOD FOR PRODUCING POLYURETHANE RESIN USING SAME | TOSOH CORP (JP) | 2020-01-08 | — | — | EP | disclosed |
| US-10442808-B2 | Pyrazolo pyrimidine derivatives and their use as MALT1 inhbitors | NOVARTIS AG (CH) | 2019-10-15 | — | — | US | disclosed |
| EP-0376859-B1 | METHOD FOR FUNCTIONALIZATION OF NUCLEOPHILES | EASTMAN KODAK COMPANY (US) | 1993-03-31 | — | — | EP | disclosed |
| US-5113011-A | Acetoacetylation | EASTMAN KODAK COMPANY (US) | 1992-05-12 | — | — | US | disclosed |
| EP-0448602-A1 | METHOD FOR FUNCTIONALIZATION OF NUCLEOPHILES | EASTMAN KODAK COMPANY (US) | 1991-10-02 | — | — | EP | disclosed |
| US-5051529-A | Transesterification, amidation and acetoacetylation of amines, alcohols, mercaptans and polymers | EASTMAN KODAK COMPANY (US) | 1991-09-24 | — | — | US | disclosed |
| EP-0418175-A2 | Isoxazoles herbicides | RHONE POULENC AGRICULTURE LTD. (GB) | 1991-03-20 | — | — | EP | disclosed |
| EP-0376859-A1 | Method for functionalization of nucleophiles | EASTMAN KODAK COMPANY (US) | 1990-07-04 | — | — | EP | disclosed |
| WO-1990006911-A1 | METHOD FOR FUNCTIONALIZATION OF NUCLEOPHILES | EASTMAN KODAK COMPANY (US) | 1990-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150345-A1 | GCN2 MODULATING COMPOUNDS AND USES THEREOF | EIF2AK4, GCN1, CLN6 | DGAT1 565/4885CYP2D6 4628/4885CA2 4232/4885 |
| US-10442808-B2 | Pyrazolo pyrimidine derivatives and their use as MALT1 inhbitors | FBP1, MMEL1, MALT1 | DGAT1 4453/4885CYP2D6 315/4885CA2 3708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.